Evidence map›Paper›PMID 35259296›Full record

ArticleACS biomaterials science & engineering2022

Multifunctional, Multivalent PIC Polymer Scaffolds for Targeting Antigen-Specific, Autoreactive B Cells.

Hendy Kristyanto, Miles D Holborough-Kerkvliet, Lianne Lelieveldt, Yvonne Bartels, Roel Hammink, Karin A J van Schie, Rene E M Toes, Kimberly M Bonger, Hans Ulrich Scherer

Open access · hybridAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Unlocking Transplant Tolerance with Biomaterials.Advanced healthcare materials · 2025
    Review
  3. Review
  4. Glycobiology of rheumatic diseases.Nature reviews. Rheumatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Hendy KristyantoDepartment of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Miles D Holborough-KerkvlietDepartment of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-8835-2355
Lianne LelieveldtDepartment of Synthetic Organic Chemistry, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Yvonne BartelsDepartment of Synthetic Organic Chemistry, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Roel HamminkDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Division of Immunotherapy, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Karin A J van SchieDepartment of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Rene E M ToesDepartment of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Kimberly M BongerDepartment of Synthetic Organic Chemistry, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.ORCID 0000-0001-9498-2620
Hans Ulrich SchererDepartment of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Leiden University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multivalent scaffolds that carry multiple molecules with immunophenotyping or immunomodulatory properties are invaluable tools for studying and modulating specific functions of human immune responses. So far, streptavidin-biotin-based tetramers have been widely used for B-cell immunophenotyping purposes. However, the utility of these tetramers is limited by their tetravalency, the inherent immunogenicity of streptavidin (a bacterial protein that can potentially be recognized by B cells), and the limited feasibility to functionalize these reagents. This has rendered tetramers suboptimal for studying rare, in particular, antigen-specific B-cell populations in the context of clinical applications. Here, we used polyisocyanopeptides (PICs), multivalent polymeric scaffolds functionalized with around 50 peptide antigens, to detect autoreactive B cells in the peripheral blood of patients with rheumatoid arthritis. To explore the potential immunomodulatory functionalities, we functionalized PICs with autoantigenic peptides and a trisaccharide CD22 ligand to inhibit autoreactive B-cell activation through interference with the B-cell receptor activation pathway, as evidenced by reduced phospho-Syk expression upon PIC binding. Given the possibilities to functionalize PICs, our data demonstrate that the modular and versatile character of PIC scaffolds makes them promising candidates for future clinical applications in B-cell-mediated diseases.

Indexed as

Arthritis, RheumatoidPolymersAutoantigensB-LymphocytesHumansPeptidesStreptavidinAutoantigensPeptidesPolymersStreptavidinanti-citrullinated protein antibodiesCD22cyclic-citrullinated peptidepolyisocyanopeptidesrheumatoid arthritis

Identifiers

PMID35259296
PMCPMC9006213
OpenAlexW4220921656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.